Tuberc Respir Dis > Volume 37(4); 1990 > Article
Tuberculosis and Respiratory Diseases 1990;37(4):419-427.
DOI: https://doi.org/10.4046/trd.1990.37.4.419    Published online December 1, 1990.
Acute Massive Pulmonary Embolism Improved by rt-PA Thrombolytic Therapy -Two Cases of Report-
Gui Hyun Nam, Dong Chull Choi, Hee Soon Chung, Young Whan Kim, Sung Koo Han, Young Soo Shim, Keun Youl Kim, Yong Choi Han
Department of Internal Medicine and Tuberculosis Research Institute, College of Medicine, Seoul National University, Seoul, Korea
중증 폐색전증 환자에서의 rt-PA 치험 2예
남귀현, 최동철, 정희순, 김영환, 한성구, 심영수, 김건열, 한용철
Abstract
Acute massive pulmonary embolism is a serious disease with high mortality rate if proper management is delayed. Thrombolytic therapy is indicated to coπect the hemodynamic derangement Urokinase and streptokinase are conventional drugs for this purpose, but their nonspecific systemic fibrinolytic activation can cause serious bleeding. Recombinant tissue type Plasminogen Activator (rt-PA) activates fibrin-bound plasminogen selectively, and is advocated as a local thrombolytic activator without systemic side effect. But there is little clinical experience on the usage of rt-PA in acute massive pulmonary embolism. We report two cases of acute massive pulmonary embolism improved obviously after rt-PA thrombolytic therapy together with review of literatures.


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next